Related references
Note: Only part of the references are listed.HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes
Kosuke Miyauchi et al.
CELL (2009)
Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State
Hillel Haim et al.
PLOS PATHOGENS (2009)
Sequestering of the Prehairpin Intermediate of gp41 by Peptide N36Mut(e,g) Potentiates the Human Immunodeficiency Virus Type 1 Neutralizing Activity of Monoclonal Antibodies Directed against the N-Terminal Helical Repeat of gp41
Elena Gustchina et al.
JOURNAL OF VIROLOGY (2008)
Characterization of the steric defense of the HIV-1 gp41 N-trimer region
Debra M. Eckert et al.
PROTEIN SCIENCE (2008)
Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor
Yiqun Deng et al.
BIOCHEMISTRY (2007)
Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion
Stephen A. Gallo et al.
RETROVIROLOGY (2006)
Functional impact of HIV coreceptor-binding site mutations
Mark J. Biscone et al.
VIROLOGY (2006)
Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants
Y Li et al.
JOURNAL OF VIROLOGY (2006)
Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation
AS Dimitrov et al.
BIOCHEMISTRY (2005)
Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV
E Gustchina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Enfuvirtide resistance mutations: Impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization
JD Reeves et al.
JOURNAL OF VIROLOGY (2005)
Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus
EJ Platt et al.
JOURNAL OF VIROLOGY (2005)
The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle
LG Abrahamyan et al.
JOURNAL OF VIROLOGY (2005)
Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins
ZH Si et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
JA Binley et al.
JOURNAL OF VIROLOGY (2004)
The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors
SA Gallo et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity
JD Reeves et al.
JOURNAL OF VIROLOGY (2004)
Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells
M Tobiume et al.
JOURNAL OF VIROLOGY (2003)
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
PF Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The HIV Env-mediated fusion reaction
SA Gallo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Direct evidence that C-peptide inhibitors of human immunodeficiency virus type 1 entry bind to the gp41 N-helical domain in receptor-activated viral envelope
NR Kilgore et al.
JOURNAL OF VIROLOGY (2003)
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
JM Binley et al.
JOURNAL OF VIROLOGY (2003)
HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation
RM Markosyan et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites
Y He et al.
JOURNAL OF VIROLOGY (2003)
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics
JD Reeves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells
M Viard et al.
JOURNAL OF VIROLOGY (2002)
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
M Cavrois et al.
NATURE BIOTECHNOLOGY (2002)
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates
H Golding et al.
JOURNAL OF VIROLOGY (2002)
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
A Trkola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process
SA Gallo et al.
BIOCHEMISTRY (2001)
Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions
E Schaeffer et al.
JOURNAL OF VIROLOGY (2001)
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion
GB Melikyan et al.
JOURNAL OF CELL BIOLOGY (2000)
A biosensor assay for studying ligand-membrane receptor interactions: Binding of antibodies and HIV-1 Env to chemokine receptors
TL Hoffman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
CA Derdeyn et al.
JOURNAL OF VIROLOGY (2000)
Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1
SE Kuhmann et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
